From: Qing-Yi decoction in participants with severe acute pancreatitis: a randomized controlled trial
 | Test group (n = 46) | Control group (n = 39) | P value |
---|---|---|---|
Organ complications | Â | Â | Â |
Heart failure, n (%)‡ | 12 (26.1) | 12 (30.8) | 0.633 |
Duration of heart failure, days median (interquartile range)§ | 0 (0–1) | 0 (0–2) | 0.449 |
Respiratory failure, n (%)‡ | 28 (60.9) | 20 (51.3) | 0.374 |
Duration of respiratory failure, days median (interquartile range)§ | 1 (0–3) | 1 (0–3) | 0.835 |
ARF, n (%)‡ | 5 (10.9) | 3 (7.7) | 0.617 |
Duration of ARF, days median (interquartile range)§ | 0 (0–0) | 0 (0–0) | 0.715 |
Hepatic failure, n (%)‡ | 11 (23.9) | 15 (38.5) | 0.147 |
Duration of hepatic failure, days median (interquartile range)§ | 0 (0–0.3) | 0 (0–4) | 0.069 |
Paralytic ileus, n (%)‡ | 44 (95.7) | 34 (87.2) | 0.157 |
Duration of paralytic ileus, days median (interquartile range)§ | 4 (2–6)a | 6 (4–8) | 0.014 |
Infection, n (%)‡ | 6 (13.0)a | 14 (35.9) | 0.013 |
ICU stay, days median (interquartile range)§ | 0 (0–0) | 0 (0–0) | 0.209 |
Use of respirator, n (%)‡ | 4 (8.7) | 9 (23.1) | 0.066 |
Use of respirator, days median (interquartile range)§ | 0 (0–0) | 0 (0–0) | 0.067 |